Katz D H, Unanue E R
J Exp Med. 1973 Apr 1;137(4):967-90. doi: 10.1084/jem.137.4.967.
A detailed analysis of the role of determinant presentation in the process of triggering immunocompetent lymphocytes has been made utilizing cell-bound hapten-carrier conjugates to elicit secondary antihapten antibody responses, primarily in vitro. The results of these experiments demonstrate that: (a) hapten-protein conjugates will attach to the surface membranes of macrophages directly, in the absence of specific antibodies, in a highly immunogenic form; (b) such macrophage-bound conjugates serve as remarkedly efficient stimuli to trigger both thymus-derived (T) and bone marrow-derived (B) cells in a specific manner, lowering the optimal threshold antigen dose (in molar terms) by several logs as compared with soluble antigen; (c) the macrophage is not unique in this regard, since fibroblasts are essentially comparable in the capacity to present antigen in highly immunogenic form; (d) cell surface-bound antigen clearly favors secondary in vitro responses of the IgG as compared with the IgM antibody class; (e) in terms of triggering B or T cells, antigen bound to macrophages in the form of immune complexes does not appear to possess any appreciable advantage over equimolar quantities of directly attached antigen; (f) the increased immunogenicity of cell-bound antigen appears to reflect certain crucial, and undefined, features of cell surface membranes and not merely the stabilization of determinants on a relatively immobile surface; and (g) although the efficiency of lymphocyte triggering is markedly enhanced by cell-bound antigen, the presence of macrophages is apparently not an absolute requirement for eliciting secondary in vitro antibody responses to soluble hapten-protein conjugates. The relevance of these observations to the nature of the signal induced upon antigen interaction by specific lymphocytes and the sequential cellular events involved in the regulatory influence of activated T cells on B cell responses to antigen is discussed. We postulate that T lymphocytes are best triggered by cell-bound antigen and that after this step the activated T lymphocytes regulate the triggering of B cells with antigen.
利用细胞结合的半抗原 - 载体缀合物引发次级抗半抗原抗体反应(主要在体外),对决定簇呈递在触发免疫活性淋巴细胞过程中的作用进行了详细分析。这些实验结果表明:(a) 在没有特异性抗体的情况下,半抗原 - 蛋白质缀合物将以高度免疫原性的形式直接附着于巨噬细胞的表面膜;(b) 这种与巨噬细胞结合的缀合物作为非常有效的刺激物,以特定方式触发胸腺来源的(T)细胞和骨髓来源的(B)细胞,与可溶性抗原相比,将最佳阈值抗原剂量(以摩尔计)降低了几个对数;(c) 巨噬细胞在这方面并非独一无二,因为成纤维细胞在以高度免疫原性形式呈递抗原的能力上基本相当;(d) 与IgM抗体类别相比,细胞表面结合的抗原明显有利于IgG的体外次级反应;(e) 就触发B细胞或T细胞而言,以免疫复合物形式与巨噬细胞结合的抗原似乎并不比等摩尔量的直接附着抗原具有任何明显优势;(f) 细胞结合抗原的免疫原性增加似乎反映了细胞表面膜的某些关键且未明确的特征,而不仅仅是决定簇在相对固定表面上的稳定;(g) 尽管细胞结合抗原显著增强了淋巴细胞触发的效率,但巨噬细胞的存在显然不是引发对可溶性半抗原 - 蛋白质缀合物的体外次级抗体反应的绝对必要条件。讨论了这些观察结果与特异性淋巴细胞抗原相互作用时诱导的信号性质以及活化T细胞对B细胞抗原反应的调节影响中涉及的连续细胞事件的相关性。我们假设T淋巴细胞最好由细胞结合抗原触发,并且在此步骤之后,活化的T淋巴细胞用抗原调节B细胞的触发。